Valo Health and Novo Nordisk expand collaboration to discover …
2 days ago · Bagsværd, Denmark and Lexington, Massachusetts, US, 8 January 2025 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease based on Valo’s extensive human dataset and computation powered by ...
Novo Nordisk swells alliance with AI firm Valo Health
1 day ago · News of the expanded agreement is a timely boost for Flagship Pioneering-backed Valo Health, which recently shelved the development of its lead in-house drug candidate for diabetic retinopathy ...
Novo Nordisk Expands AI Partnership With Valo Health for …
1 day ago · Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs (Reuters) - Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding ...
Novo Nordisk Adds Obesity and Diabetes to AI Drug Research …
2 days ago · Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of ...
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI …
1 day ago · Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial intelligence (AI) partnership aimed at discovering and developing up to 20 ...
Valo Health and Novo Nordisk expand collaboration to discover …
2 days ago · Bagsværd, Denmark and Lexington, Massachusetts, US, 8 January 2025 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop ...
Novo Nordisk expands AI partnership with Valo Health for …
1 day ago · Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and ...
Novo Adds $1.9 Billion to Valo Deal for AI-Driven Obesity Drugs
2 days ago · Novo Nordisk A/S is expanding a drug-development deal with Valo Health to use artificial intelligence to seek new medicines for obesity and diabetes, pledging an additional $1.9 billion to the partnership.. Valo will now get up-front and near-term milestone payments of $190 million and is eligible for as much as $4.6 billion in the longer term, including potential milestones for as many as 20 ...
Novo Nordisk, Valo Health Expand Drug Discovery and
2 days ago · Novo Nordisk expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human data and artificial intelligence. The deal ...
Valo | Valo Health and Novo Nordisk to collaborate to discover …
Sep 24, 2023 · Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programs. Novo Nordisk licenses three preclinical drug discovery programs in cardiovascular diseases discovered and developed by Valo using the Opal Computational Platform™
- Some results have been removed